Dual Involvement of Growth Arrest-Specific Gene 6 in the Early Phase of Human IgA Nephropathy

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Nagai, Kojiro ^a   Miyoshi, Masashi ^a   Kake, Takei ^b   Fukushima, Naoshi ^b   Matsuura, Motokazu ^a   Shibata, Eriko ^a   Yamada, Satoshi ^a   Yoshikawa, Kazuhiro ^a   Kanayama, Hiro omi ^a   Fukawa, Tomoya ^a   Yamaguchi, Kunihisa ^a   Izaki, Hirofumi ^a   Mima, Akira ^a   Abe, Naoko ^a   Araoka, Toshikazu ^a   Murakami, Taichi ^a   Kishi, Fumi ^a   Kishi, Seiji ^a   Tominaga, Tatsuya ^a   Moriya, Tatsumi ^c   Abe, Hideharu ^a   Doi, Toshio ^a   more..

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Chugai Research Institute for Medical Science Inc   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AXL PROTEIN; CELL PROTEIN; DTK PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 6; PROTEIN P27; UNCLASSIFIED DRUG; GROWTH ARREST-SPECIFIC PROTEIN 6; SIGNAL PEPTIDE;

ADULT; ANIMAL CELL; ARTICLE; CELL COUNT; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GLOMERULUS; GROWTH ARREST SPECIFIC GENE 6 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IN VITRO STUDY; KIDNEY BIOPSY; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; UPREGULATION; CELL CULTURE; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PODOCYTE;

ANIMALIA; MURINAE;

CELLS, CULTURED; ENDOTHELIAL CELLS; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; IN VITRO TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESANGIAL CELLS; PODOCYTES;

EID: 84879474790     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066759     Document Type: Article

References (30)

1. Yanagita M, Arai H, Ishii K, Nakano T, Ohashi K, et al. (2001) Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol 158: 1423-1432.
2. Yanagita M, Ishimoto Y, Arai H, Nagai K, Ito T, et al. (2002) Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest 110: 239-246.
3. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, et al. (2003) Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 278: 18229-18234.
4. Nagata K, Ohashi K, Nakano T, Arita H, Zong C, et al. (1996) Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 271: 30022-30027.
5. Yanagita M, Ishii K, Ozaki H, Arai H, Nakano T, et al. (1999) Mechanism of inhibitory effect of warfarin in mesangial cell proliferation. J Am Soc Nephrol 10: 2503-2509.
6. Funakoshi H, Yonemasu T, Nakano T, Matumoto K, Nakamura T, (2002) Identification of Gas6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons. J Neurosci Res 68: 150-160.
7. Crosier KE, Hall LR, Lewis PM, Morris CM, Wood CR, et al. (1994) Isolation and characterization of the human Dtk receptor kinase. Growth Factors 11: 137-144.
8. Nystrom J, Fierlbeck W, Granqvist A, Kulak SC, Ballermann BJ, (2009) A human glomerular SAGE transcriptome database. BMC Nephropathy 10: 13.
9. Tumlin JA, Madaio MP, Hennigar R, (2007) Idiopathic IgA nephropathy: Pathogennesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol 2: 1054-1061.
10. D'Amico G, (2004) Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 24: 179-196.
11. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA Nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76: 546-556.
12. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA Nephropathy: rationale, clinicopathoogical correlations, and classification. Kidney Int 76: 534-545.
13. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, et al. (1996) Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50: 1230-1239.
14. Qiu LQ, Sinniah R, Hsu SI, (2004) Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy. Lab Invest 84: 1112-1125.
15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, et al. (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kid Dis 53: 982-992.
16. Tominaga T, Abe H, Ueda O, Goto C, Nakahara K, et al. (2011) Activation of BMP4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. J Biol Chem 286: 20109-20116.
17. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, et al. (1997) Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258.
18. Murakami T, Abe H, Nagai K, Tominaga T, Takamatsu N, et al. (2010) Trophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritis. Am J Nephrol 32: 505-521.
19. Demarchi F, Verardo R, Varnum B, Brancolini C, Schneider C, (2001) Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem 276: 31738-31744.
20. O'Donnell K, Harkes IC, Dougherty L, Wicks IP, (1999) Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway. Am J Pathol 154: 1171-1180.
21. Graham DK, Dawson TL, Mullaney DL, Snodgrass HR, Earp HS, (1994) Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ 5: 647-657.
22. Chen J, Carey K, Godowski PJ, (1997) Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 14: 2033-2039.
23. Asao R, Asanuma K, Kodama F, Akiba-Takagi M, Nagai-Hosoe Y, et al. (2012) Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. Clin J Am Soc Nephrol 7: 1385-1393.
24. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, et al. (2011) High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant 26: 3581-3588.
25. Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, et al. (2011) Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.Nephrol Dial Transplant. 26: 3229-3236.
26. Ding H, He Y, Li K, Yang J, Li X, et al. (2007) Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 123: 227-234.
27. Zhao N, Hou P, Lv J, Moldoveanu Z, Li Y, et al. (2012) The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 82: 790-796.
28. Onda K, Ohsawa I, Ohi H, Tamano M, Mano S, et al. (2011) Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function. BMC Nephrol 12: 64.
29. Liu LL, Jiang Y, Wang LN, Liu N, (2012) Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy. Clin Exp Immunol 169: 148-155.
30. Ebefors K, Granqvist A, Ingelsten M, Mölne J, Haraldsson B, et al. (2011) Role of glomerular proteoglycans in IgA nephropathy. PLoS One 6: e18575.